Human T-cell leukemia virus type 1 (HTLV-1) Tax affects cellular genomic stability and senescence. As yet, the mechanism(s) for these events caused by Tax is incompletely understood. Here, we show that Tax expression in primary human cells induces reactive oxygen species (ROS), which elicits DNA damage and the expression of senescence marker. Treatment with a ROS scavenger or knockdown of Tax expression by small interfering RNA (siRNA) abrogated Tax-induced DNA damage and the expression of senescence marker. Our data suggest that ROS induction explains Tax-induced cellular DNA damage and cellular senescence.
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T cell leukemia/lymphoma (ATLL) (2, 17, 26, 34) . The viral Tax oncoprotein is implicated in the initiation of cellular transformation (5, 26) . Tax has been reported to cause pleiotropic effects, including induction of cellular DNA damage and chromosomal instability (CIN) (1, 16, 23, 29) . Tax-induced DNA damage and CIN could trigger cellular senescence as a reactive response for protection against oncogenesis (19, 28) . To date, how Tax causes DNA damage and CIN remains incompletely explained.
Oncoproteins can generate DNA damage in two ways. First, the oncoprotein can neutralize cellular checkpoints and repair processes, thereby allowing damage caused by ambient events (ultraviolet [UV] light, carcinogens, etc.) to manifest. Second, the oncoprotein can directly create DNA lesions. To date, while many studies have shown that Tax can obstruct the cell's checkpoints and DNA damage repair mechanism(s) (6, 9, 12, 14, 21, 22) , it has not been demonstrated that Tax can directly create DNA damage. Oncoproteins, such as Ras, have been reported to modulate intracellular reactive oxygen species (ROS) (20) . ROS is a DNA-damaging agent (7, 10, 27) . We thus explored if Tax, like Ras, increases cellular ROS in cells.
For our assays, we employed normal human foreskin fibroblasts (BJ cells; ATCC, Manassas, VA) at fewer than 10 passages, primary human cord blood CD4 ϩ T cells (Lonza, Walkersville, MD), and the HTLV-1-negative human acute lymphocytic leukemia T-Jurkat cell line (kindly provided by Yuetsu Tanaka of the University of the Ryukyus). To examine ROS induction, we tested wild-type Tax, a Tax point mutant (the S258A mutant, which is intact for CREB but defective for NF-B activity), and a second Tax point mutant (the L320G mutant, which is intact for NF-B but defective for CREB activity) (32) . To construct Tax-expressing retroviral vectors, we used the pMSCV-neo vector (Clontech, Mountain View, CA), which expresses genes of interest at a moderate level. We employed this vector-promoter because we have found that high overexpression of Tax would rapidly induce apoptosis in BJ cells (data not shown). Wild-type Tax and the two Tax mutants were cloned into the pMSCV-neo vector, and retroviral particles that express Tax were produced using the packaging cell line PT-67 in accordance with the manufacturer's instructions (Clontech, Mountain View, CA). Normal human foreskin BJ fibroblasts, Jurkat cells, and primary human CD4 ϩ T cells were then transduced with viral particles that express wild-type Tax or either of the two Tax mutants. Transduced cells were then selected for 7 days with G418 (Invitrogen, Carlsbad, CA), and Tax expression was verified by reverse transcription-PCR (RT-PCR) (Fig. 1A) . BJ-Tax, BJ-Tax 258, and BJ-Tax 320 (Fig. 1A, lanes 3 , 4, and 5) cells showed distinct evidence for Tax expression, whereas the negative-control cells (BJ and BJ-Neo) (Fig. 1A, lanes 1 and 2) did not.
We next investigated ROS levels using BJ, Jurkat, and primary CD4 ϩ T cells. To measure intracellular ROS, a peroxidesensitive reagent (CM-H 2 DCF-DA; Molecular Probes, Eugene, OR) was used. The cells were stained using 5 M CM-H 2 DCF-DA for 10 min at 37°C and observed under a fluorescence microscope. Increased ROS was indicated by higher CM-H 2 DCF-DA fluorescence in the experimental cells than in the control cells. Indeed, BJ-Tax cells (Fig. 1B) showed strong fluorescent signals, with 70% of the cells staining brightly positive for ROS in a representative low-power field. In comparison, the two Tax mutants (BJ-Tax 258 and BJ-Tax 320) ( Ͼ80% positive for ROS (Fig. 1B) . The results from three independent experiments were quantified and analyzed (Fig.  1C) ; these results demonstrated statistically significant differences in ROS production between wild-type Tax, Tax S258A, and Tax L320G (Fig. 1C ).
To confirm further that ROS generation was due to Tax expression, we designed three small interfering RNAs (siRNAs) (siRNAs 1, 2, and 3) that target Tax (Fig. 1D ). The effectiveness of the siRNAs in knocking down Tax mRNA was verified (Fig.  1D ). siRNA 1 was found to be the most effective (Fig. 1D ) and was employed in subsequent experiments. We repeated ROS induction using wild-type Tax in Jurkat cells (Fig. 1E ) and primary CD4 ϩ T cells (Fig. 1F) . In Jurkat cells, the ROS induced by Tax was efficiently reduced by transfected siRNA that targeted Hokkaido System Science (Hokkaido, Japan). Tax Fig. 1E and F) , consistent with a direct role for Tax in ROS induction. Does Tax-ROS production correlate with cellular DNA damage? To address this question, cellular damage was assayed by measuring the presence of accumulated DNA damage-associated repair protein ␥H2AX (4, 18). We compared Neo-and Tax-expressing BJ ( Fig. 2A and B) and Jurkat ( Fig.  2C and D) cells by immunostaining using mouse anti-human ␥H2AX antibody (GeneTex, Irvine, CA), followed by secondary incubation with anti-mouse Alexa568 (Molecular Probe, Eugene, OR). BJ-Tax and Jurkat-Tax cells had strong nuclear ␥H2AX staining, consistent with increased DNA damage ( Fig.  2A, B , C, and D, nontreated), while BJ-Neo and Jurkat-Neo cells did not ( Fig. 2A, B, C, and D, nontreated) . Transfection of siRNA targeted to Tax significantly reduced the induction of ␥H2AX in Jurkat-Tax cells (Fig. 2C and D, Tax siRNA treated), supporting a role for Tax in ␥H2AX-induction. To establish that the accumulation of ␥H2AX in BJ-Tax and Jurkat-Tax cells was due to ROS, we treated Neo-and Taxexpressing cells with the ROS scavenger N-acetyl cysteine (NAC) and then stained for ␥H2AX (Fig. 2A, B , C, and D, NAC treated). NAC treatment effectively erased the ␥H2AX signals in both BJ-Tax and Jurkat-Tax cells, consistent with the interpretation that the DNA damage-associated ␥H2AX observed in these cells was a result of ROS ( Fig. 2A, B, C, and D) . Three independent experiments were performed, and the collective findings verified the statistically significant differences between Neo-and Tax-expressing cells and between Tax-expressing cells without and with NAC or siRNA treatments ( Fig. 2B and D) .
A more direct measure of DNA damage than staining for ␥H2AX is monitoring for single-and double-stranded DNA breaks by employing the "comet" assay (comet assay kit; Stressgene, Ann Arbor, MI). The visualization of a "comet" tail in an individual cell indicates DNA strand breakage. To perform the comet analysis, cells after 1, 3, and 5 days of Tax transduction were collected and embedded in agarose gel. They were then processed for electrophoresis after sodium hydroxide treatment. Among BJ-Tax (Fig. 3A and B) and Jurkat-Tax (Fig. 3C and D) cells, the majority showed comet tails, indicative of DNA breaks (Fig. 3A and C, nontreated) . In contrast, Neo-or Tax mutant-expressing BJ and Jurkat cells displayed negligible numbers of comet cells (Fig. 3A, B , C, and D, nontreated). NAC or siRNA treatment significantly reduced the comet tailing (Fig. 3A, B , C, and D, NAC treated, and B and C, Tax siRNA treated), further corroborating a link between Tax-induced ROS and cellular DNA damage.
A frequent physiological reactive response of nontransformed cells to DNA damage is senescence (3, 8, 33) . When wild-type Tax was expressed in BJ cells, many cells showed irregularly shaped nuclei, and the overall cell growth rate in cultured BJ-Tax cells was decreased in comparison to the level for BJ control cells (data not shown). To explore the relationship between Tax expression and cell senescence in BJ (Fig. 4A and B) and primary CD4 ϩ T (Fig. 4C and D) cells, we stained the cells for senescence markers (staining for senescence-associated beta-galactosidase [SA ␤-Gal] was performed for BJ cells [senescence detection kit; Trevigen, Gaithersburg, MD], and staining for SEN1, also known as MORF4 [35] , was performed for primary CD4 ϩ T cells [Abcam, Cambridge, MA]). Elsewhere, Ras overexpression has been reported by others to induce cell senescence (8, 33) . Thus, we used Ras expression as a positive senescence control. Indeed, the numbers of SA ␤-Gal staining cells in Tax-and Ras-expressing BJ cells were increased more than 3-fold over the number for BJ-neo control cells (Fig. 4A and B) . Because primary CD4 ϩ T cells that express Tax showed poor cytoplasmic SA ␤-Gal visualization due to the inherently small cytoplasmic volume of primary lymphocytes, we chose to immunostain for a nuclear senescence marker, SEN1 (also known as MORF4 [35] ). Tax distinctly induced SEN1 expression in primary human CD4 ϩ T cells, and the frequency of senescent cells was significantly Fig. 4C and D) . We also asked if the increased expression of senescence markers could be relieved by the ROS scavenger, NAC (Fig.  4A, B, C, and D) . Treatment of cells with NAC reduced SA ␤-Gal expression in both Tax-and Ras-transduced BJ cells (Fig. 4A) , with statistically significant changes (Fig. 4B) . NAC treatment of Tax-expressing primary human CD4 ϩ T cells and transfection of siRNA targeting Tax into the corresponding cells also suppressed SEN1 in a statistically significant fashion (Fig. 4C and D) .
Here, to our knowledge, we show for the first time that Tax expression in primary human cells induces ROS with accompanying DNA damage and reactive cellular senescence. Previously, Tax expression in cultured cells has been reported to result in genomic instability, cell senescence, and apoptosis (19, 24, 28, 36) ; however, the inciting cause(s) for these cellular changes was not characterized. Our present findings from Tax expression in normal fibroblasts, CD4
ϩ primary T cells, and Jurkat cells suggest that some of above-mentioned changes occur via induction of ROS (Fig. 2, 3 , and 4). Our results further indicate that Tax-ROS-caused DNA damage can lead to reactive cellular senescence in nontransformed human cells.
DNA damage induced by Tax and other oncoproteins has been documented previously (11, 31, 37) . Earlier, it was suggested that such oncogene-induced DNA damage may have occurred indirectly through accelerated G 1 cell cycle progression, which might in itself be mutagenic (11) . Our current observation that Tax induces ROS is consistent with reports of ROS induction by Ras (20, 33, 38) , c-Myc (37), and EpsteinBarr virus (EBV) EBNA-1 protein (13) . Others have proposed that Myc and Ras may activate ROS through a mitogen-activated protein kinase (MAPK) pathway (37) and that EBNA-1 generates ROS through the NOX2 oxidase (13). We do not currently know how Tax triggers ROS, but on the basis of the results from the Tax S258A and L320G mutants, this activity likely requires the activation of both CREB and NF-B. In addition to oxidases, cellular peroxiredoxins and thioredoxins also play roles in regulating ROS. In this regard, we note with interest that downregulation of peroxiredoxins (which increases cellular ROS) has been shown to induce NF-B (15), which is highly activated in Tax-expressing cells (30) . Further investigation is needed to understand more completely the details of how Tax influences the oxidation-reduction equilibrium in human cells, which could also involve antioxidative thioredoxin proteins (25) . A more complete mechanistic insight into the redox balance in ATLL cells would be useful for potential development of anti-ROS agents that might interrupt HTLV-1 leukemogenesis.
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